#mdr tb

[hannamaytumble]

Friendly reminder that Johnson and Johnson haven’t committed to not enforcing their patents in all the high burden multi drug resistant tuberculosis nations.

[iyemarathichiyenagari1971]

क्षयरोगमुक्तीसाठी नव्या प्रभावी उपचार पद्धतीस मान्यता

भारतात बहु औषध-प्रतिरोधक क्षयरोगावर नवीन लहान आणि अधिक प्रभावी उपचार पद्धती सादर करण्यास केंद्रीय आरोग्य मंत्रालयाने दिली मान्यता. नवी दिल्ली – पंतप्रधान नरेंद्र मोदी यांच्या संकल्पनेनुसार, शाश्वत विकास उद्दिष्टांतर्गत क्षयरोग या आजाराचे उच्चाटन करण्याच्या निर्धारित जागतिक उद्दिष्टीत कालावधीपेक्षा पाच वर्षे अगोदर,  2025 पर्यंत देशाला क्षयरोगमुक्त करण्यासाठी, केंद्रीय आरोग्य आणि कुटुंब कल्याण…

क्षयरोगमुक्तीसाठी नव्या प्रभावी उपचार पद्धतीस मान्यता

[mtatva-blog]

Drug Resistant TB: A Condition where Drugs Become Ineffective

Drug Resistant TB: A Condition where Drugs Become Ineffective

What is Drug Resistance? Drug resistance is the reduction in effectiveness of a drug such as an antimicrobial, anthelmintic or an antineoplastic in curing a disease or condition. The term is used in the context of resistance that pathogens or cancers have “acquired”, that is, resistance has evolved. Tolerance is a decrease in response to a drug that is used repeatedly. Multi-drug resistant…

View On WordPress

[theteriobrienshow-blog]

"Refugees" Bring Multi-Drug Resistant TB to Wisconsin

“Refugees” Bring Multi-Drug Resistant TB to Wisconsin

Third World “refugees” (actually economic migrants/future democrats) are bringing TB, including drug resistant strains, into the United States. Here in various posts at teriobrien.com, such as this one and this one, and on The Teri O’Brien Show, we have been following the serious public health issues raised by the importation of the Third World to our country, including the return of…

View On WordPress

[bidhuan]

Inilah Terapi Obat yang Lebih Murah dari WHO untuk Tuberkulosis Resisten Multi Obat

Inilah Terapi Obat yang Lebih Murah dari WHO untuk Tuberkulosis Resisten Multi Obat

Inilah Terapi Obat yang Lebih Murah dari WHO untuk Tuberkulosis Resisten Multi Obat. Beberapa hari lalu Organisasi Kesehatan Dunia (World Health Organization/WHO) telah menerbitkan rekomendasi baru yang berusaha untuk mempercepat deteksi dan meningkatkan angka kesembuhan bagi penderita tuberkulosis resisten multi obat (MDR-TB). [Baca : Rekomendasi Terbaru dari WHO untuk Atasi Tuberkulosis…

View On WordPress

[bidhuan]

Rekomendasi Terbaru dari WHO untuk Atasi Tuberkulosis Resisten Multi Obat

Rekomendasi Terbaru dari WHO untuk Atasi Tuberkulosis Resisten Multi Obat

Rekomendasi Terbaru dari WHO untuk Atasi Tuberkulosis Resisten Multi Obat. World Health Organization (WHO) kemarin (12/5) meluncurkan rekomendasi baru yang bertujuan untuk mempercepat deteksi dan meningkatkan hasil pengobatan tuberkulosis resisten multi obat Multidrug resistant tuberculosis (MDR Tb) melalui penggunaan tes diagnostik cepat baru dan lebih pendek, serta rejimen pengobatan yang lebih…

View On WordPress

[pocketglobalhealth]

Supercharged Tuberculosis, Made in India

A patient with extensively drug-resistant TB flew from Mumbai to Chicago, and the deadly disease could become an infamous export due to problems in India's public health system

[scirp]

Read the full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=49558 DOI: 10.4236/jtr.2014.23018 Author(s) Haregewoin Bezu, Daniel Seifu, Getnet Yimer, Tesfamariam Mebrhatu Affiliation(s) Department of Medical Biochemistry, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Department of Medical Biochemistry, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. Research and Technology Transfer, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia. All Africa Leprosy, TB Rehabilitation and Training Center, Armauer Hansen Research Institute (AHRI/ALERT), Addis Ababa, Ethiopia. ABSTRACT Introduction: The key to successful elimination of tuberculosis (TB) is treatment of cases with optimum chemotherapy. Irrational anti-TB drug use over time has led to drug-resistant TB. The treatment of MDR-TB with second line drugs is long, complex and costly, and has a considerable rate of adverse effects. The level of ADR reporting is low in Ethiopia due to different factors. This Study conducted in a selected treated area in Addis Ababa, Ethiopia and helped the health care centers to understand the prevalence of ADR related MDR-TB and be aware of those adverse effects in order to detect them early and be prepared to take proper steps when they occur. Aim of the Study: To determine the prevalence and risk factor of adverse drug reactions associated treatments of Multidrug Resistant tuberculosis. Method: This was a cross sectional study, which was conducted between March 2012 and February 2013 at St. Peter TB specialized hospital and AHRI/ALERT. 73 MDR TB patients, who were on MDR TB treatments, enrolled to the study. Adverse Drug Reactions associated MDR TB treatments were assessed by patient history review and questionnaire. Chemistry laboratory was used to test renal function, thyroid function, liver enzyme and potassium level. Result: In 72 patients, at least two ADRs were found. The mean age of the study population (Mean ± SD) was 28 ± 8.8. In this study the most commonly found adverse drug reactions (ADRs) were: Anorexia 83.3%, Nausea and vomiting 82%, Gastritis 64%, Arteralgia 47%, Skin rash and itching 45%, Headache 29.2%, Depression 22.2% and Blurred vision 19.4%. Using binary logistic regression model older age (COR 8.71, 95% [CI] 1.06 - 71.9), alcoholism (COR 4.05, 95% [CI] 1.05 - 15.6), smoking (COR 0.24, 95% [CI] 0.06 - 0.87) and concomitant drug intake (COR 0.14, 95% [CI] 0.03 - 0.76) were independent predictors for ADRs. Conclusion: The prevalence of ADRs related MDR TB treatments is high. To minimize ADR occurrence, ADR predictors should be integrated into the clinical pathway. Monitoring of liver function, renal function, TSH and level of potassium during MDR TB treatment, helps to avoid complication caused by therapy and increase the adherence to the treatment. KEYWORDS MDR TB, ADR, Second Line Anti-TB Treatment gjreww140912